In concomitance with a decline in the naïve repertoire, COVID-19 severe disease is also associated with more terminally differentiated CD8+ cytotoxic T cells with reduced functionality (116) and that is particularly common in patients over the age of 80 years (117). This evidence concerns the gene CD8A and COVID-19.